Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03034512 · ClinicalTrials.gov registry record
Alpers Huttenlocher Natural History Study
A clinical trial, sponsored by Columbia University.
- Terminated
- Registry status
- 2
- Enrollment target
NCT03034512: Clinical Trial study, sponsored by Columbia University.
NCT03034512 is a clinical trial that was terminated before completion, run by Columbia University. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03034512 was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
This is a natural history study of Alpers Huttenlocher Syndrome. Patients will be followed over time to assess clinical symptoms for the purpose of expanding knowledge of this disorder in the medical community.
Primary Outcome
age at onset of first symptom versus POLG mutation type
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2014-01 |
| Est. Completion | 2022-07-27 |
Why NCT03034512 stopped before completion
NCT03034512 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03034512 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03034512 about?
NCT03034512 is a clinical study titled "Alpers Huttenlocher Natural History Study". This is a natural history study of Alpers Huttenlocher Syndrome. Patients will be followed over time to assess clinical symptoms for the purpose of expanding knowledge of this disorder in the medical community.
What is the current status of trial NCT03034512?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2014-01. Estimated completion is 2022-07-27.
Who is sponsoring clinical trial NCT03034512?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia